期刊文献+

帕金森病不同分级与血尿酸的关系分析 被引量:3

下载PDF
导出
摘要 目的分析帕金森病(Parkinson’s disease,PD)不同分级与血尿酸的关系。方法回顾性病例分析,连续收集2010年3月—2013年3月年山西医科大学第一医院神经内科住院确诊为帕金森病(PD)的患者72例。对纳入研究患者的性别、年龄、教育程度、文化程度、婚姻状况、血尿酸、体重指数等情况进行记录。结果本研究共搜集原发性帕金森患者72例,男性39例,女性33例;年龄69.1岁±5.28岁;按Hoehn-Yahr分级,帕金森早期组(1~2级)18例,帕金森中期组(2.5~3级)34例,帕金森晚期组(4~5级)20例。随帕金森病情进展,3组间血尿酸水平无明显变化规律。早期组血尿酸水平较中期组血尿酸水平低具有统计学意义(P〈0.05),而晚期组尿酸水平较中期组血尿酸水平低,但无统计学意义(P〉0.05)。血尿酸水平与PD病情分级无相关(r=-0.051,P=0.253)。结论帕金森病病程的各个阶段与血尿酸水平尚未发现无明显相关关系。
出处 《中西医结合心脑血管病杂志》 2015年第9期1125-1126,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献8

  • 1Meam J, Bhlowmick BK, Hobson P. Accuracy of diagnosis inpa tients with presumed Parkinson' s disease [J]. Age Ageing, 1999,28(2) : 99102.
  • 2Hoehn M, Yahr M. Parkinsonism : Onset, progression and mortal- ity[ J]. Neurology, 1967,17(5) : 427 - 442.
  • 3Goetz CG, Poewe W, Rascol O, et al. Movement disorder socie- ty task force report on the hoehn and yahr staging scale: Status and recommendations. The movement disorder society task force on rating scales for Parkinson' s disease[J]. Movement Disorders,2004,19(9) : 1020 - 1028.
  • 4张振涛,曹学兵,孙圣刚.帕金森病多巴胺神经元死亡的分子机制[J].中国康复,2006,21(6):402-404. 被引量:17
  • 5Jenner P. Oxidati vestressin Parkinson's disease[J]. Ann Neu- roh 2003,53(Suppl3) : S26 - S38.
  • 6Du Y,Chen CP, Tseng CY, et al. Astroglia mediated effects of Uricacid to protect spinal cord neurons from glutamate toxicity [J]. Glia,2007,55(5) :463 - 472.
  • 7De Lau LM,Koudstaal PJ,Hofman A, etal. Serum uric acid levels and the risk of Parkinson disease[J]. Ann Neuml, 2005, 58:797 - 800.
  • 8Weiss Kopf MG, O' Reilly E, Chen H, et al. 5. 285- Plasma urate and risk of Parkinson's disease[J]. Am J Epdemioh 2007, 166(5) 561 - 567.

二级参考文献18

  • 1[1]SPIRA PJ,SHARPE DM,HALLIDAY G,et al.Clinical and Pathological Features of a Parkinsonian Syndrome in a Family with an Ala53Thr Alpha-Synuclein Mutation[J].Ann Neurol(S0364-5134),2001,49(3):313-319.
  • 2[2]SRIRAM SR,LI X,KO HS,et al.Familial-associated Mutations Differentially Disrupt the Solubility,Localization,Binding and Ubiquitination Properties of Parkin[J].Hum Mol Genet(S0964-6906),2005,14(17):2571-2586.
  • 3[3]HEALY DG,ABOU-SLEIMAN PM,WOOD NW.Genetic Causes of Parkinson's Disease:UCHL-1[J].Cell Tissue Res(S0302-766X),2004,318(1):189-194.
  • 4[4]MOMOSE Y,MURATA M,KOBAYASHI K,et al.Association Studies of Multiple Candidate Genes for Parkinson's Disease Using Single Nucleotide Polymorphisms[J].Ann Neurol(S0364-5634),2002,51(1):133-136.
  • 5[5]BONIFATI V,RIZZU P,NANBAREN MJ,et al.Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-onset Parkinsonism[J].Science(S0036-8075),2003,299(5604):256-259.
  • 6[6]SHINBO Y,NIKI T,TAIRA T,et al.Proper SUMO-1 Conjugation is Essential to DJ-1 to Exert Its Full Activities[J].Cell Death Differ(S1350-9087),2006,13(1):96-108.
  • 7[7]GLICKMAN MH,CIECHANOVER A.The Uiquitin-Proteasome Proteolytic Pathway:Destruction for the Sake of Construction[J].Physiol Rev(S0031-9333),2002,82(2):373-428.
  • 8[8]BENCE NF,SAMPAT RM,KOPITO RR.Impairment of the Ubiquitin-proteasome System by Protein Aggregation[J].Science(S0036-8075),2001,292(5521):1552-1555.
  • 9[9]OSTREROVA N,PETRUCELLI L,FARRER M,et al.a-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins[J].J Neurosci(S0270-6474),1999,19(14):5782-5791.
  • 10[10]ROSS CA,PICKART CM.The Ubiquitin-Proteasome Pathway in Parkinson's Disease and Other Neurodegenerative Diseases[J].Trends Cell Biol(S0270-8924),2004,14(12):703-711.

共引文献16

同被引文献50

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部